This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Affymetrix And DNA Link Sign Partnership For Forensic Test Development For Human Identification

Affymetrix, Inc. (NASDAQ: AFFX) and DNA Link, Inc., a Korean genomics-based biotechnology company, today announced that they have signed a Powered by AffymetrixTM (PbA) Program agreement in which DNA Link, Inc. obtains a worldwide license to develop and commercialize a forensic test for comprehensive human identification and other diagnostic tests using Affymetrix’ microarray technology and the Korea FDA (KFDA) cleared GeneChip® System 3000Dx v.2.

AccuID ®Chip is a novel SNP marker based array for personal identification which can be applied to a variety of forensic samples, including degraded DNA samples. This array utilizes DNA Link’s unique approach of combining Affymetrix’ target resequencing array technology and multiplexing PCR technology to genotype hundreds of SNP markers in a single experiment to obtain high quality data and a wide variety of information – all with high throughput and cost efficiency.

Dr. Jong-Eun Lee, CEO of DNA Link, said, “The advantage of using SNP markers is that they possess lower mutation rate than STR markers, thus are more stable in terms of inheritance which could aid parentage testing, kinship analysis, ethnicity, or predicting phenotypic characteristics. This novel forensic test, AccuID ®Chip, can be used complementarily with existing STR tests and to build a more comprehensive forensic database. We are pleased to join the ranks of other PbA Program partners, such as Roche Diagnostics and Pathwork Diagnostics in adopting the Affymetrix technology.”

“We are very pleased to have DNA Link join our Powered by Affymetrix program in which we help partners to develop novel molecular diagnostic tests for personalized healthcare. DNA Link being our first partner in Korea will also provide our other PbA partners access to the Korean personalized genomics market,” said Dara Wright, Vice President, Clinical Applications Marketing at Affymetrix.


AccuID ®Chip is not available for in vitro diagnostic use in the United States.

Affymetrix ®, the Affymetrix logo, Powered by Affymetrix™, GeneChip ® and all other trademarks are the property of Affymetrix, Inc. AccuID ®Chip is trademark of DNA Link and all other trademarks are the property of their respective owners.

SOURCE: Affymetrix, Inc.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,830.95 +54.52 0.32%
S&P 500 1,983.13 -3.92 -0.20%
NASDAQ 4,752.9390 -28.3250 -0.59%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs